Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Cancer Lett. 2016 Jul 5;380(2):413–423. doi: 10.1016/j.canlet.2016.07.001

Table 1.

human γδ T cell ligands

Subset Antigen Reference(s)
Vγ1.3Vδ2 Histidyl-tRNA synthetase (51)
Vγ4Vδ5 Endothelial protein C receptor (EPCR) (52)
Vγ9Vδ2 Alkylamines (53)
Phosphoantigens (pAgs) Butyrophilin 3A1
(BTN3A1)+ Pyrophosphate
molecules
(38)
(E)-4-hydroxy-3-methyl-
but-2-enyl pyrophosphate
(HMBPP)
(54)
Isopentenyl pyrophosphate
(IPP)
(55)
Bromohydrin
pyrophosphate (BrHPP)
(56)
Endogenous mevalonate
metabolites
(57)
Agonistic monoclonal
antibody (called 20.1)
(58)
Surface mitochondrial
F1-ATPase-related
structure/Apolipoprotein
A-I
(59, 60)
ULBP4(a soluble
isoform of RAET1E)
(61)
Ligands on Daudi &
Molt-4 cell lines
(62, 63)
Human MutS homolog (64)
Vδ1 Lipohexapeptides (65)
CD1c–expressing cells (66)
Vγ2Vδ8(clone) HSV glycoprotein I (67)
Vδ1 (IELs) MICA & MICB (25, 68)
Vδ1 (blood γδ T cells) CD1d–sulphatide (69)
CD1d-α-GalCer (70)
Various Phycoerythrin (71)

HSV, herpes simplex virus; MICA, MHC class I polypeptide-related sequence A; MICB, MHC class I polypeptide-related sequence B; RAET1E, Retinoic acid early transcript 1E, ULBP4, UL16-binding protein4